Collectively, specific activation or forced overexpression of either ErbB2 or ErbB3 attenuates VPA-induced apoptosis and inhibition of cell proliferation/survival in pancreatic cancer cells via constitutive activation of downstream Akt and MAPK signaling pathways. This evidence concerns the gene ERBB2 and familial pancreatic carcinoma.